Top

About VETmAb BIO

A proven team in search of the best therapies
for our companion animals
ABOUT THE COMPANY

Pioneers in veterinary biotech developing
sophisticated therapeutics for dogs and cats

It’s not every day that a team gets the opportunity to put decades of collective experience and proven success to work for a second time — but that’s just what the VETmAb BIO team is doing. As the former founding team of KindredBio, a pioneering company in veterinary biotechnology, our co-founders built a world-class team, received multiple FDA approvals, and sold the company to one of the world’s largest veterinary pharmaceutical companies. As the founding team of VETmAb BIO, we intend to take every learning and best practice to bring innovative therapeutics to veterinarians who treat our dog and cat family members.

Proven team of scientists and operators with deep industry expertise

World-renowned protein engineers specializing in therapeutics for dogs and cats

Deep relationships with veterinarians who are in need of innovative solutions for their patients

Seperator Border

Why VETmAb BIO?

The meaning behind
the name

VETmAb BIO is focused on bringing the best monoclonal antibodies (mAbs) to veterinarians. The name of our company reflects our expertise and passion.

Meet Our Team Of Experts

At VETmAb BIO, we are a proud team of individuals who are operating at the very top of our fields. Our scientists are thought leaders at the forefront of mAb biotechnology. Our operators are experts in capital-efficient drug development, and our executives have proven their success to shareholders time and time again. We are deeply ingrained in the veterinary industry and know what our veterinarian colleagues need to effectively and safely treat their patients.

TEAM AND BOARD MEMBERS
Denise Beavers

Denise Bevers

Co-founder, President & CEO, Board Member

Denise is an empowering, creative, and highly impactful entrepreneur who loves a challenge and building something new from the ground up. With over 30 years of drug development experience, Denise believes in investing...

Read Denise’s Bio
Hangjun Zhan

Hangjun Zhan, PhD

Co-founder, Chair of the Scientific Advisory Committee, Board Member

Hangjun is Chief Scientific Officer at Alamar Bioscience. Hangjun is a highly regarded protein biochemist/ biophysicist and executive with 28 years of drug discovery experience. Most recently, Hangjun was CSO...
Read More

Read Hangjun’s Bio
Richard Chin

Richard Chin, MD

Co-founder, Chair of the Board

Richard is Managing Director of Ascendant Venture, a family office and venture studio investing in startups. He is the Founder and CEO of Infinita Life Science, a biopharmaceutical company developing...
Read More

Read Richard’s Bio
Kristy Longpre

Kristy Longpre, PhD

Director of Operations

Kristy is a proactive, forward-thinking, creative and agile leader with over 15 years of drug development experience in human and veterinary pharmaceuticals. Kristy was previously an associate director in project...
Read More

Read Kristy’s Bio
Olivia Chang

Olivia Chang

Head of Accounting and Finance

Olivia Chang is a business leader with nearly 20 years of experience establishing and growing companies and financial departments at multiple organizations. Her ability to create structure out of ambiguity...
Read More

Read Olivia’s Bio
OPPORTUNITIES FOR PARTICIPATION

Sign your clinic up
for our clinical trials

COMING SOON

 

Seperator Border

STAY CONNECTED WITH US

Receive research updates, clinical trial information, and more.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.